Vnitr Lek 2006, 52(10):864-872

Thyroid autoimmunity in adults with diabetes mellitus type 1. Own experience gained by 11-year monitoring

K. Vondra*, J. Vrbíková, I. Šterzl
Endokrinologický ústav, Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.

The results of study on thyroid autoimmunity and its clinical importance gained during 11-year follow-up of 47 adults with type 1 diabetes mellitus (DM1) are presented. The study proved the preponderance of women among subject affected with thyroid autoimmunity, the autoantibodies against thyroid gland (T-Ab) were significantly more often detected in women compared to men (68% vs. 32%, p < 0.05). Also, serious forms of thyroid autoimmunity manifested with persistence of both T-Ab, faster development of subclinical hypothyroidism (TSH > 4.5 mIU/l in 100% within 4 years after first detection of T-Ab positivity, and within 8 years after DM1 manifestation, respectively), and diffuse hypoechogenic pattern at thyroid gland ultrasonography (USG) were significantly more often observed in women compared to men (45% vs. 12%, p< 0.01). These patients often had small thyroid gland (77% of subjects had volume below 25th percentile of control subjects at the 11th year of follow-up) and presence of thyreopathy in the first degree relatives. No difference between men and women was observed in persistence of thyroid peroxidase autoantibodies (anti-TPO) solely (20% vs. 23%); milder clinical course of thyroid disease was observed in these subjects (the fist detection of TSH > 4.5 mIU/l in the 9th year of follow-up). These patients had varied findings at USG examination with focally/diffuse hypoechogenic/ non-homogenous thyroid gland, and 50% of subjects had thyroid gland volume above 95th percentile in the 11th year of follow-up. Among subjects without thyroid autoimmunity men prevailed (68% vs. 32% women, p < 0.01), and in the 11th year of follow-up the USG finding was often abnormal (thyroid gland volume above 95th percentile of the controls in more than 60% of subjects, trend towards nodulisation). Except for 1 subject, TSH did not exceed 4.5 mIU/l. These results obtained from the Czech population constitute the basis for our recommendation to screen regularly markers of thyroid autoimmunity in patients with DM1. Ultrasonographic examination, that is able to detect sings of thyroid immunopathy in many subjects before first manifestation of T-Ab, is the most sensitive according to both our experience and the published data. For clinical practice, determination of TSH once a year in all DM1 subjects, and of anti-TPO in DM1 women in fertile age is recommended. Ultrasonographic examination should be carried out in case of pathologic results of these tests.

Keywords: diabetes mellitus, type 1; thyroid autoimmunity; thyroid gland autoantibodies; autoimmune thyroiditis; thyroid gland function; thyroid gland ultrasonography

Received: June 14, 2006; Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vondra K, Vrbíková J, Šterzl I. Thyroid autoimmunity in adults with diabetes mellitus type 1. Own experience gained by 11-year monitoring. Vnitr Lek. 2006;52(10):864-872.
Download citation

References

  1. Aghini-Lombardi F, Antonangeli L, Martino E et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrionol Metab 1999; 84: 561-566. Go to original source...
  2. Barova H, Perusicova J, Hill M et al. Anti-GAD-positive patients with Type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti GAD-negative patients with Type 1 and Type 2 diabetes mellitus. Physiol Res 2004; 53: 279-286. Go to original source...
  3. Běhanová M, Zamrazil V, Vondra K et al. Klinická charakteristika tyreopatií u diabetiků středního věku. DMEV 1999; Suppl 1: 21-22.
  4. Bianchi G, Montanari P, Fabbri A et al. Thyroid volume in type 1 diabetes patients without overt thyroid disease. Acta Diabetol 1995; 32: 49-52. Go to original source... Go to PubMed...
  5. Fernandez-Soto L, Gonzales A, Lobon JA et al. Thyroid peroxidase autoantiboides predict poor metabolic control and need for thyroid treatment in pregnant IDDM women. Diabetes Care 1997; 20: 1524-1528. Go to original source... Go to PubMed...
  6. Geul KW, van Sluisveld ILL, Grobbee DE et al. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women. Clin Endocrinol 1993; 39: 275-280. Go to original source... Go to PubMed...
  7. Hansen D, Bennedbaek FN, Hansen LK et al. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999; 140: 512-518. Go to original source... Go to PubMed...
  8. Marcocci C, Vitti P, Cetani F. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 1991; 72: 209-213. Go to original source... Go to PubMed...
  9. Matějková-Běhanová M, Zamrazil V, Vondra K et al. Autoimmune thyroiditis in non-obese subjects with initial diagnosis ob Type 2 diabetes mellitus. J Endocrionol Invest 2002; 25: 779-784. Go to original source... Go to PubMed...
  10. McCanlies E, O'Leary LA, Foley T et al. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 1998; 83: 1548-1551. Go to original source...
  11. Perros P, McCrimmon RJ, Shaw G et al. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic medicine 1995; 12: 622-627. Go to original source... Go to PubMed...
  12. Prázný M, Škrha J, Límanová Z et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol Res 2005; 54: 41-48. Go to original source...
  13. Rubello D, Gasparoni P, Rota G et al. Functional meaning of scintigraphic and echographic patterns, and of circulating anti-peroxidase antibodies in asymptomatic chronic thyroiditis. Q J Nucl Med 1996; 40: 359-364.
  14. Sandell EB, Kolthoff IM. Micro determination of iodine by a catalytic method. Mikrochemika Acta 1937: 19-25. Go to original source...
  15. Schroner Z, Lazurova I, Petrovičová J. Autoimunitné tyreopatie u diabetikov. Vnitř Lék 2006; 52: 137-143. Go to PubMed...
  16. Steiss JO, Otten A, Graef V et al. Thyroid gland ultrasound and urinary iodine excretion in children and adolescents with type I diabetes mellitus. Klin Pediatr 1996; 208: 327-333. Go to original source...
  17. Škvor J. Štítná žláza u 13letých dětí, zdravých, diabetiků a alergiků. Kandidátská disertační práce. Endokrinologický ústav Praha, 1993.
  18. Vanderpump MPJ, Tunbridge WMG. The epidemiology of autoimmune thyroid Disease. In: Volpe R. Contemporary Endocrinology: autoimmune endocrinopathies. Totowa (NJ, USA): Humana Press Inc 1999: 141-162. Go to original source...
  19. Vanderpump MPJ, Tunbridge WMG, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinol 1995; 43: 55-68. Go to original source... Go to PubMed...
  20. Volpe R. The immunology of human autoimmune thyroid disease. In: Volpe R. Contemporary Endocrinology. Autoimmune Endocrinopathies. Totowa (NJ, USA): Humana Press Inc 1999: 217-244. Go to original source...
  21. Vondra K, Vrbíková J, Ivašková E et al. Výskyt protilátek proti tyreoglobulinu a proti mikrosomům u dospělých diabetiků I. typu a jejich možný klinický význam. Vnitř Lék 1996; 42: 767-771. Go to PubMed...
  22. Vondra K, Vrbíková J, Dvořáková K. Thyroid gland diseases in adult patients with diabetes mellitus. Minerva endocrinologica 2005; 30: 217-236. Go to PubMed...
  23. Vondra K, Vrbíková J, Bendlová B et al. Differences in Type I Diabetes Mellitus of Young Adults with and without Thyroid Autoimmunity. Exp Clin Endocrinol Diabetes 2005; 113: 404-408. Go to original source... Go to PubMed...
  24. Vondra K, Vrbíková J, Šterzl I et al. Thyroid autoantibodies and their clinical relevance in young adults with Type-1 diabetes during the first 12-years after DM 1 onset. J Endocrionol Invest 2004; 27: 728-732. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.